Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone

NCT03116295 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Opicapone (OPC)

Sponsor

Bial - Portela C S.A.